6th Evolution Summit

Clinical studies are being launched at a growing pace, the practice of off-shoring is increasing, safety and efficacy requirements are becoming more rigorous and focus on improving recruitment and retention rates is being ramped up/ Now more than ever, faster, more economically efficient methods of generating social valuable information which can produce good quality data and maximize clinical trial opportunities is crucial. If development is to keep pace with the demands of this evolving industry, the implementation of systems, processes and methods that improve the advancements, success and quality of global clinical trials is a must.

The primary objective of the 6th Evolution Summit is to explore the key aspects and issues related to clinical trial best practices and their application as business drivers for innovation and growth. The Summit’s program topics have been pinpointed and validated by senior executives from the clinical trials community as the top critical issues they face.

Key issues for 2013 include:

Establishing Strategic Alliances with Outside Sources – collaborating successfully to expedite drug development

New Strategies for Simplifying Protocol Design and Improving Trials Performance – reviewing the growing body of research on protocol complexity and its impact on development performance

Disruptive Innovation to Transform Clinical Development – introducing various methods to drive innovation

Site Selection and Feasibility – identifying appropriate clinical trial sites at home

Pharmacogenomics in Early-Phase Clinical Trials – incorporating pharmacogenomic factors into the drug development process

The Social Media Era - determining the effect of e-recruitment as an enrollment tool

Analyzing the Ethical and Scientific Role of Emerging Markets in Clinical Research – pinpointing recent trends in globalization

Developing Predictive Biomarkers as a Companion Diagnostic – offering the ability to target subsets of test patient and improve efficacy